Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Costello, CL"'
Autor:
Solh, M, Bahlis, NJ, Raje, NS, Costello, CL, Dholaria, B, Levy, MY, Tomasson, MH, Dube, H, Damore, MA, Lon, HK, Basu, C, Skoura, A, Chan, EM, Trudel, S, Jakubowiak, A, Chu, MP, Gasparetto, C, Dalovisio, A, Sebag, M, Lesokhin, AM
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2021 43 Supplement 1:S195-S196
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Costello, Claire Louise.
Thesis (Ph.D.)--Pacific Graduate School of Psychology, 1993.
Source: Dissertation Abstracts International, Volume: 54-06, Section: B, page: 3335.
Source: Dissertation Abstracts International, Volume: 54-06, Section: B, page: 3335.
Externí odkaz:
http://wwwlib.umi.com/dissertations/fullcit/9324583
Autor:
Badros AZ; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland, United States., Foster L; University of Virginia, Charlottesville, Virginia, United States., Anderson LD Jr; University of Texas Southwestern Medical Center, Dallas, Texas, United States., Chaulagain CP; Cleveland Clinic Florida, Weston, Florida, United States., Pettijohn EM; Cancer & Hematology Centers of Western Michigan, Grand Rapids, Michigan, United States., Cowan AJ; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States., Costello CL; UCSD, La Jolla, California, United States., Larson S; University of California, Los Angeles, Santa Monica, California, United States., Sborov DW; Huntsman Cancer Institute / University of Utah, Salt Lake City, Utah, United States., Shain KH; Moffitt Cancer Center, Tampa, Florida, United States., Silbermann R; Oregon Health & Science University, Portland, Oregon, United States., Shah N; University of California San Francisco, San Francisco, California, United States., Chung A; University of California San Francisco, San Francisco, California, United States., Krevvata M; Janssen Research & Development, LLC, Spring House, Pennsylvania, United States., Pei H; Janssen, Titusville (Hopewell Township), New Jersey, United States., Patel S; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, United States., Khare V; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, Pennsylvania, United States., Cortoos A; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, United States., Carson R; Janssen R&D, Springhouse, Pennsylvania, United States., Lin T; Johnson and Johnson Innovative Medicine, Horsham, Pennsylvania, United States., Voorhees PM; Levine Cancer Institute, Atrium Health Wake Forest Baptist, Charlotte, North Carolina, United States.
Publikováno v:
Blood [Blood] 2024 Sep 27. Date of Electronic Publication: 2024 Sep 27.
Autor:
Wang HY; Division of Laboratory and Genomic Medicine, Department of Pathology, University of California San Diego Health Sciences, La Jolla, California, USA., Louis HMS; Division of Laboratory and Genomic Medicine, Department of Pathology, University of California San Diego Health Sciences, La Jolla, California, USA., Costello CL; Division of Blood and Marrow Transplant, Department of Medicine, University of California San Diego Health Sciences, La Jolla, California, USA., Murray SS; Division of Laboratory and Genomic Medicine, Department of Pathology, University of California San Diego Health Sciences, La Jolla, California, USA., Dell'Aquila ML; Division of Laboratory and Genomic Medicine, Department of Pathology, University of California San Diego Health Sciences, La Jolla, California, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jul; Vol. 205 (1), pp. 364-367. Date of Electronic Publication: 2024 May 12.
Autor:
Rifkin RM; Rocky Mountain Cancer Centers/US Oncology Research, Denver, CO 80218, USA., Costello CL; Department of Medicine, Division of Blood & Marrow Transplantation, Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA., Birhiray RE; Hematology Oncology of Indiana/American Oncology Network, Indianapolis, IN 46260, USA., Kambhampati S; Kansas City Veterans Affairs Medical Center, Kansas City, MO 64128, USA., Richter J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Abonour R; Indiana University School of Medicine, Indianapolis, IN 46202, USA., Lee HC; M.D. Anderson Cancer Center, Houston, TX 77030, USA., Stokes M; Evidera, Data Analytics, St-Laurent, Quebec, H4T 1V6, Canada., Ren K; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02412, USA., Stull DM; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA., Cherepanov D; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02412, USA., Bogard K; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA., Noga SJ; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA., Girnius S; TriHealth Cancer Institute, Cincinnati, OH 45247, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Jan; Vol. 20 (3), pp. 131-143. Date of Electronic Publication: 2023 Oct 09.
Autor:
Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada. nbahlis@ucalgary.ca., Costello CL; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Raje NS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Levy MY; Department of Medical Oncology, Baylor Scott and White Health, Dallas, TX, USA., Dholaria B; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Solh M; Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA, USA., Tomasson MH; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA., Damore MA; Oncology Research and Development, Pfizer Inc., San Diego, CA, USA., Jiang S; Early Clinical Development, Pfizer Inc., San Diego, CA, USA., Basu C; Early Clinical Development, Pfizer Inc., San Diego, CA, USA., Skoura A; Early Clinical Development, Pfizer Inc., Collegeville, PA, USA., Chan EM; Oncology Research and Development, Pfizer Inc., South San Francisco, CA, USA., Trudel S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Jakubowiak A; Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA., Gasparetto C; Department of Medicine, Duke University Cancer Institute, Durham, NC, USA., Chu MP; Cross Cancer Institute, Edmonton, AB, Canada., Dalovisio A; Department of Hematology and Oncology, Ochsner Health, New Orleans, LA, USA., Sebag M; Cedars Cancer Center, McGill University Health Center, Montreal, QC, Canada., Lesokhin AM; Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, NY, USA.
Publikováno v:
Nature medicine [Nat Med] 2023 Oct; Vol. 29 (10), pp. 2570-2576. Date of Electronic Publication: 2023 Oct 02.
Autor:
Thompson MA; Aurora Cancer Care, Advocate Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI,. Electronic address: michael.thompson@tempus.com., Boccadoro M; Division of Hematology, University of Torino, Torino, Italy., Leleu X; Pôle Régional de Cancérologie, Department of Hematology, CHU La Milétrie-Poitiers, Poitiers, France., Vela-Ojeda J; Department of Hematology, UMAE Hospital de Especialidades Centro Medico La Raza IMSS, Mexico City, Mexico., van Rhee F; University of Arkansas for Medical Sciences, Little Rock, AR., Weisel KC; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Rifkin RM; Rocky Mountain Cancer Centers/US Oncology Research, Denver, CO., Usmani SZ; Levine Cancer Institute, Charlotte, NC., Hájek R; Department of Hemato-oncology, University Hospital Ostrava, and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Cook G; Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK., Abonour R; Indiana University School of Medicine, Indianapolis, IN., Armour M; Mijelom CRO, Croatian Myeloma Support Association, Zagreb, Croatia., Morgan KE; Myeloma Patients Europe, Brussels, Belgium., Yeh SP; China Medical University Hospital, Taichung City, P.R.China., Costello CL; University of California San Diego, La Jolla, CA., Berdeja JG; Department of Hematology, Tennessee Oncology and Sarah Cannon Research Institute, Nashville, TN., Davies FE; Perlmutter Cancer Center, NYU Langone, New York, NY., Zonder JA; Department of Malignant Hematology, Barbara Ann Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI., Lee HC; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Omel J; The Central Nebraska Myeloma Support Group, Grand Island, NE., Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health Monash University, Melbourne, Australia., Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Hungria VTM; Department of Hematology, Clinica São Germano and Santa Casa Medical School, São Paulo, Brazil., Puig N; Hematology Department, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Fu C; First Affiliated Hospital, Soochow University, Suzhou Jiangsu, P.R.China., Ferrari RH; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Ren K; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA., Stull DM; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Chari A; Department of Hematology-Oncology, Mount Sinai School of Medicine, New York, NY.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Mar; Vol. 23 (3), pp. e171-e181. Date of Electronic Publication: 2022 Dec 07.
Autor:
Costello CL; University of California San Diego, La Jolla, CA.
Publikováno v:
Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2022 Dec 09; Vol. 2022 (1), pp. 539-550.